Health and Me on MSN
KRAS-targeted vaccine shows promise in fighting pancreatic cancer, triggers strong immune response in early trial
A new vaccine trial conducted on humans for pancreatic cancer, one of the deadliest malignancies in the world, showed immense ...
Experimental KRAS Vaccine Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at the Johns Hopkins Kimmel Cancer Center and its Skip Viragh Center for Pancreatic Cancer report that an ...
LENSai™ powered by HYFT® technology Identifies a single multi-factorial target conserved across all dengue serotypes. AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ:IPA) ...
Researchers used AI to identify an mpox protein that triggers a strong immune response in mouse models. The discovery could pave the way to more effective vaccines and therapies for mpox. The ...
The manufactured product will be used in proprietary immunization protocols at IPA’s Canadian facility. These studies, conducted in a rabbit model, are designed to evaluate whether the vaccine ...
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...
Manufacturing of validated dengue epitope underway; proprietary immunization studies in rabbit model to assess monoclonal antibody (mAb) responses. AUSTIN, Texas--(BUSINESS WIRE)-- ImmunoPrecise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results